5132-03-31 | ||||
2014-01-22 | Downgrade | Wedbush | Outperform to Neutral | |
2013-12-16 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2013-11-15 | Reiterated Rating | Needham & Company LLC | Hold | |
1970-01-01 |
5132-03-31 | ||||
2014-01-22 | Downgrade | Wedbush | Outperform to Neutral | |
2013-12-16 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2013-11-15 | Reiterated Rating | Needham & Company LLC | Hold | |
1970-01-01 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In PATH 174 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Sumitomo Mitsui Trust Holdings, Inc. | 29.19M |
Vanguard Group, Inc | 28.46M |
Nikko Asset Management Americas, Inc. | 28.18M |
BlackRock Inc. | 16.52M |
ALKEON CAPITAL MANAGEMENT LLC | 15.47M |
FMR LLC | 10.32M |
GOLDMAN SACHS GROUP INC | 9.62M |
SC US (TTGP), LTD. | 8.63M |
Meritage Group LP | 5.84M |
STATE STREET CORP | 5.07M |
GEODE CAPITAL MANAGEMENT, LLC | 4.79M |
TWO SIGMA INVESTMENTS LLC | 4.69M |
COATUE MANAGEMENT LLC | 4.24M |
RENAISSANCE TECHNOLOGIES LLC | 3.94M |
Mirae Asset Global Investments Co., Ltd. | 3.28M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
BVP GP LLC | 7.77% (2433429) | PATH / |
BioAdvance Ventures L P | 0.86% (268879) | PATH / |